The Six Five Summit: AI Unleashed 2025 Explores the Future of Artificial Intelligence
Austin, Texas, May 12, 2025 (GLOBE NEWSWIRE) — Six Five Media today announced the speaker lineup for its annual Six Five Summit, set to take place virtually from June 16-19, 2025. This year's summit, themed 'AI Unleashed 2025,' will unpack the transformative power of artificial intelligence and its impact across various industries.
The Six Five Summit: AI Unleashed will deliver four days of exclusive, on-demand content, featuring insights from the industry's most influential voices at the center of AI, tech, and their markets. Attendees will gain access to fresh video sessions and interactive thought leadership from top tech executives, with new content released daily.
This year's agenda will include sessions exploring the intersection of AI with 14 different track topics: Automotive
DevOps
Cloud Infrastructure
Enterprise AI
Intelligent Edge
Enterprise Applications
Collaboration
Modern Work
Cybersecurity
Semiconductors
Sustainability
Data & Observability
Quantum Computing
And, as the AI landscape continues to expand exponentially, this year's program will introduce a new track focusing on Channel Ecosystems & Marketing.
'We're excited to present a dynamic and comprehensive program that addresses the most pressing questions and exciting possibilities in the world of AI. The Six Five Summit eliminates the barriers of traditional conferences, offering direct access to the discourse shaping AI's newest chapter, without the constraints of travel or scheduling conflicts.' – Patrick Moorhead, Founder, CEO, and Chief Analyst at Moor Insights & Strategy
Check Out The Six Five Summit 2024 Recap Reel
The previous Six Five Summit featured 60+ sessions from 40+ companies and 35+ C-Suite Execs across the tech landscape.
In addition to this year's show opener, Michael Dell, Rene Hass CEO of Arm Holdings and Aaron Levie CEO of Box will each be featured as day-opening keynote speakers. Additional confirmed participants for 2025 include CXO's and Presidents from HP, Coherent, Lattice Semiconductor, AWS, Google Cloud, Marvell, Salesforce, IonQ, Oracle, Samsung Semiconductor, Palo Alto Networks, RingCentral, T-Mobile, Dell Technologies, SAP, Iron Mountain, and others, to be announced.
'AI is rapidly evolving, reshaping industries and creating unprecedented opportunities,' said Daniel Newman, Founding Partner of Six Five Media and CEO of The Futurum Group. 'The Six Five Summit: AI Unleashed will bring together the brightest minds in technology to explore the latest advancements, challenges, and opportunities in AI. We'll be diving deep into the key trends shaping the future of AI.'
The summit will provide insider perspectives on the next wave of AI innovation from the leaders driving these technologies to market. Sessions will span critical industry sectors, including Semiconductors, Devices, Cloud, and Cybersecurity, and examine their intersection with pivotal AI trends such as: Agentic AI: Exploring the rise of autonomous AI agents.
Exploring the rise of autonomous AI agents. Co-Pilots: Examining the integration of AI assistants into workflows.
Examining the integration of AI assistants into workflows. Frontier Models: Discussing the development and implications of cutting-edge AI models.
Discussing the development and implications of cutting-edge AI models. SLMs (Small Language Models): Analyzing the growing importance of efficient and specialized language models.
Registration for The Six Five Summit: AI Unleashed 2025 is now open. For more information on speakers, agenda, and registration, please visit https://www.sixfivemedia.com/summit
About The Six Five Summit
The Six Five Summit is an annual, digital event hosted by Six Five Media, bringing together the leading voices in technology to discuss the most important trends and innovations transforming industries and markets. The summit provides a platform for in-depth analysis, thought leadership, and networking, with top tech CEO's and C-suite executives paired with insights and commentary from top analysts, pundits, and strategists in the industry, delivered directly to attendees' screens.
About Six Five Media
Six Five Media is a global technology media, and events company. They provide industry-leading B2B technology analysis and produce high-profile thought leadership content from the top voices in tech.
Attachment
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
10 minutes ago
- Yahoo
New Online Casinos Canada: RoboCat Launches New Games and Bonuses
RoboCat Reinvents Itself with a New Brand Identity to Capture Canada's New Online Casinos Audience by Introducing Bigger Bonuses and New Games Toronto, June 06, 2025 (GLOBE NEWSWIRE) -- RoboCat Casino – one of the fastest-growing new online casinos in Canada – has recently launched a new brand identity with the goal of reaching, engaging and on-boarding Canada's new online casinos audience. The new brand identity includes a reinvented platform design and interface - with a strategic use of colors and navigation design-, new games and bigger bonuses and promotions for new and existing players. Amongst the updates launched by RoboCat in Canada, the new promotions and bonuses stand out as they provide players with a larger amount of free spins, free deposit money and generous cashback bonuses, in addition to enjoying access to exclusive giveaways and extra bonuses. The renovated welcome bonus by RoboCat rewards new players with 100% extra on their first deposit + 200 free spins + a surprise bonus known as the Crab Bonus, which rewards customers with up to $300 CAD for Bets on a New Brand Identity to Stand Out from the New Online Casinos in Canada RoboCat has recognized they needed to reinvent their brand identity in order to compete efficiently with the new online casinos in Canada, which are introducing innovative and exciting features such as new real money games, bigger bonuses, faster payouts and outstanding mobile support and compatibility. The new online casino states they could not afford to stay behind the curve, and this is why they have invested an important percentage of their yearly budget to introduce these upgrades in record time, to push through the second half of 2025 and reach their goal of onboarding 50% more players by the end of the year. RoboCat Strives to Be the Name Behind Endless Gaming Options Amongst the New Online Casinos in Canada As part of a major brand upgrade aimed at winning over Canadian players, RoboCat has expanded its catalogue with thousands of new real money games, focusing on the country's most popular verticals, including online slots, table games, and live dealer games. The addition of new titles has increased the size of RoboCat's catalogue to 8,000+ games, which places it as one of the new online casinos in Canada with the largest selection of real money games, offering new and registered players access to new online gambling experiences. RoboCat has mainly focused on online slots, which is the most popular type of online gambling game in Canada, adding world class titles to their catalogue. The most relevant additions according to RoboCat Canada are: Gates of Olympus (Pragmatic Play) Book of Dead (Play'n GO) Big Bass Bonanza (Pragmatic Play) Starburst (NetEnt) Cleopatra (IGT) Mega Moolah (Games Global) Sweet Bonanza (Pragmatic Play) 9 Masks of Fire (Gameburger Studios) Buffalo King Megaways (Pragmatic Play) Gold Blitz (Fortune Factory Studios) Book of 99 (Relax Gaming) Blood Suckers (NetEnt) Mega Joker (NetEnt) Gonzo's Quest (NetEnt) Age of the Gods (Playtech) Thunderstruck II (Microgaming) Immortal Romance (Microgaming) Legacy of Dead (Play'n GO) 100x Ra (Lightning Box) Sweet Bonanza (Pragmatic Play)RoboCat's New Brand Goals Involve Being Recognized as the Online Casino with the Best Bonuses RoboCat has expressed their wish for Canadian players to recognize and recommend it as the new online casino with the best bonuses and promotions, since it is a strong selling point for attracting and on-boarding new players, as well as strengthening the relationships with existing customers. RoboCat has launched new promotions in addition to their renovated welcome bonus, which include a 50 free spins reload bonus, reload bonuses, 10-15% cashback and free cash rewards for active players, offering new and existing players a new type of online gambling experience. In addition, RoboCat has revealed they have reduced the rollover requirements for all of their new bonuses and promotions, making it easier for players to turn the bonus money into real cash they can cash out without restrictions. Therefore, the company has expressed how the introduction of these new bonuses and promotions contributes towards improving the perception of their brand in the Canadian market, as their goal is to position themselves amongst the top 10 online casinos in Canada, which has become one of the most competitive industries in the iGaming has also confirmed they are going to keep releasing new bonuses and promotions, as they believe it is one of the most powerful tools in their hands for capturing a bigger share of the Canadian online gambling industry. RoboCat Launches New Website Interface and Structure RoboCat has implemented a series of interface and accessibility upgrades designed to enhance the overall user experience across its platform. The redesigned layout offers a cleaner, more intuitive navigation structure and delivers improved responsiveness across all device types, including desktops, smartphones, and tablets. These improvements enable players to locate games more efficiently, manage their accounts with greater ease, and enjoy uninterrupted gameplay. By prioritizing usability and cross-device accessibility, RoboCat continues to advance its goal of providing a seamless and inclusive online gaming environment for all Canadian players over 18 years old to enjoy. These major upgrades focus on the gaming experience and UX provides easier access to all the sections of RoboCat in Canada, including the new games and new bonuses. Therefore, they all form part of the same strategy which aims at strengthening their brand in Canada in order to compete with the rising number of new online casinos entering the local Improves Payments Speed and Banking Experience RoboCat has strengthened its payment infrastructure to deliver faster, more reliable deposit and withdrawal services for its users. Through new partnerships with leading payment providers and the integration of advanced transaction technology, the platform now supports instant deposits and significantly faster withdrawals. These improvements reduce wait times and improve transparency across all financial interactions. With broader payment method support and a simplified user interface, RoboCat is focused on creating a smooth, secure, and efficient banking experience that meets the expectations of today's online casino players. RoboCat has also revealed it is one of their goals for Canadian players to associate their brand with easy, fast and seamless payouts, which is one of the main features an online casino can offer in the modern context of online gambling. Therefore, new and existing users can now enjoy the instant deposits and faster withdrawals provided by RoboCat, which support a more immersive and exciting online gambling the upgrades – new games, new bonuses, faster payouts and a new interface for a UX — are available now, giving access to all players instantly. About RoboCat Casino RoboCat is a newly launched online casino in Canada offering an extensive catalogue of over 8,000 games, along with a range of promotions including free spins, deposit bonuses, and cashback rewards. With fast payouts, full mobile compatibility, and dedicated customer support, RoboCat is designed to deliver a seamless and engaging online gaming experience for players across the country. Live Chat: Email: support@ Disclaimer and Affiliate Disclosure The information contained in this article is for general informational purposes only. While every effort has been made to ensure the accuracy and timeliness of the content, no guarantees are made as to its completeness or correctness. The article may contain typographical errors or factual inaccuracies, and readers are advised to independently verify all promotional details, bonus terms, game availability, and other information by visiting the official RoboCat Casino website or contacting their support team directly. This content does not constitute legal, financial, or professional advice. Any decisions made based on the information herein are at the sole discretion and risk of the reader. Online gambling is subject to local laws and regulations; users are solely responsible for ensuring that they are in compliance with applicable laws in their jurisdiction before participating in any online gaming activities. This article is intended strictly for individuals aged 18 years or older (or the legal age in their jurisdiction, if higher). The publisher of this content may receive financial compensation or other forms of consideration from RoboCat Casino or affiliated marketing partners through referral links or promotional arrangements. This includes but is not limited to commissions earned from sign-ups, deposits, or other actions taken by users who engage with RoboCat Casino through links or banners included in this article. All statements regarding product features, performance, bonuses, or offers are made by RoboCat Casino and have not been independently verified by the publisher. The publisher, its partners, and all syndication channels make no representations or warranties regarding the legitimacy, reliability, or expected outcomes of using RoboCat Casino services. No liability is assumed by the publisher or its syndication partners for any loss or damages incurred in connection with the use of the featured services. This content is sponsored and may contain marketing language or promotional claims. Readers are encouraged to perform their own research and exercise due diligence before registering or transacting with any online casino. For the latest information on bonuses, terms and conditions, or available games, please refer to the official RoboCat Casino website. CONTACT: Live Chat: Email: support@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, June 06, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that on June 2, 2025 (the 'Grant Date'), ORIC granted a total of 39,100 non-qualified stock options and 6,500 restricted stock units to three new non-executive employees who began their employment with ORIC in May 2025. These inducement grants were granted pursuant to the ORIC Pharmaceuticals, Inc. 2022 Inducement Equity Incentive Plan, subject to recipient's continued employment or service through each applicable vesting date. The stock options have an exercise price equal to the closing price of ORIC's common stock on the Grant Date. Twenty-five percent (25%) of the shares subject to the stock options will vest on the one (1) year anniversary of the Grant Date, with one thirty-sixth (1/36th) of the remaining shares vesting each one-month period thereafter. One-third (1/3rd) of the restricted stock units will vest on each of the first three anniversaries of the Grant Date. The inducement grants are subject to the terms and conditions of the applicable stock option and restricted stock unit agreements and the ORIC Pharmaceuticals, Inc. 2022 Inducement Equity Incentive Plan. The inducement grants were approved by ORIC's Compensation Committee of the Board of Directors, as required by Nasdaq Rule 5635(c)(4), and were granted as a material inducement to employment in accordance with Nasdaq Rule 5635(c)(4). About ORIC Pharmaceuticals, Inc. ORIC Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to improving patients' lives by Overcoming Resistance In Cancer. ORIC's clinical stage product candidates include (1) ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 (PRC2) via the EED subunit, being developed for prostate cancer, and (2) ORIC-114, a brain penetrant inhibitor that selectively targets EGFR exon 20, HER2 exon 20 and EGFR atypical mutations, being developed across multiple genetically defined cancers. Beyond these two product candidates, ORIC® is also developing multiple precision medicines targeting other hallmark cancer resistance mechanisms. ORIC has offices in South San Francisco and San Diego, California. For more information, please go to and follow us on X or LinkedIn. Cautionary Note Regarding Forward-Looking StatementsThis press release contains forward-looking statements as that term is defined in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release that are not purely historical are forward-looking statements. Such forward-looking statements include, among other things, statements regarding the vesting of the inducement grants; target indications for ORIC's product candidates; the potential advantages of ORIC's product candidates; and plans underlying ORIC's clinical trials and development. Words such as 'believes,' 'anticipates,' 'plans,' 'expects,' 'intends,' 'will,' 'goal,' 'potential' and similar expressions are intended to identify forward-looking statements. The forward-looking statements contained herein are based upon ORIC's current expectations and involve assumptions that may never materialize or may prove to be incorrect. Actual results could differ materially from those projected in any forward-looking statements due to numerous risks and uncertainties, including but not limited to: risks associated with the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics and operating as an early clinical stage company; ORIC's ability to develop, initiate or complete preclinical studies and clinical trials for, obtain approvals for and commercialize any of its product candidates; changes in ORIC's plans to develop and commercialize its product candidates; the potential for clinical trials of ORIC's product candidates to differ from preclinical, initial, interim, preliminary or expected results; negative impacts of health emergencies, economic instability or international conflicts on ORIC's operations, including clinical trials; the risk of the occurrence of any event, change or other circumstance that could give rise to the termination of ORIC's license and collaboration agreements; the potential market for our product candidates, and the progress and success of competing therapeutics currently available or in development; ORIC's ability to raise any additional funding it will need to continue to pursue its business and product development plans; regulatory developments in the United States and foreign countries; ORIC's reliance on third parties, including contract manufacturers and contract research organizations; ORIC's ability to obtain and maintain intellectual property protection for its product candidates; the loss of key scientific or management personnel; competition in the industry in which ORIC operates; general economic and market conditions; and other risks. Information regarding the foregoing and additional risks may be found in the section entitled 'Risk Factors' in ORIC's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission (the 'SEC') on May 5, 2025, and ORIC's future reports to be filed with the SEC. These forward-looking statements are made as of the date of this press release, and ORIC assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements, except as required by law. Contact:Dominic Piscitelli, Chief Financial info@ sesión para acceder a tu cartera de valores
Yahoo
an hour ago
- Yahoo
PolyPid to Host Conference Call and Webcast to Discuss D-PLEX₁₀₀ SHIELD II Phase 3 Trial Topline Results on Monday, June 9, 2025
PETACH TIKVA, Israel, June 06, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD), ('PolyPid' or the 'Company'), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it will host a conference call and webcast to report topline data for the SHIELD II Phase 3 trial, evaluating D-PLEX100 for the prevention of surgical site infections in patients undergoing abdominal colorectal surgery, on Monday, June 9, at 8:30 a.m. ET. To ensure you are connected prior to the beginning of the call, PolyPid suggests registering a minimum of 5 minutes before the start of the call. Conference Call Dial-In & Webcast Information: Date: Monday, June 9, 2025 Time: 8:30 AM Eastern Time Conference Call: Webcast: About PolyPid PolyPid Ltd. (Nasdaq: PYPD) is a late-stage biopharma company aiming to improve surgical outcomes. Through locally administered, controlled, prolonged-release therapeutics, PolyPid's proprietary PLEX (Polymer-Lipid Encapsulation matriX) technology pairs with Active Pharmaceutical Ingredients (APIs), enabling precise delivery of drugs at optimal release rates over durations ranging from several days to months. PolyPid's lead product candidate D-PLEX100 is in Phase 3 clinical trial for the prevention of abdominal colorectal surgical site infections. In addition, the Company is currently in preclinical stages to test the efficacy of OncoPLEX for the treatment of solid tumors, beginning with glioblastoma. For additional Company information, please visit and follow us on Twitter and LinkedIn. Contacts:PolyPid Ltd. Ori WarshavskyCOO – US908-858-5995IR@ Investors:Brian RitchieLifeSci Advisors212-915-2578britchie@
